Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2026-01-24 @ 9:56 PM
Study NCT ID:
NCT04736394
Status:
RECRUITING
Last Update Posted:
2022-02-22
First Post:
2021-01-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Study to Evaluate the Safety and Efficacy of APL-1202 as a Single-agent Oral Treatment Versus Intravesical Instillation of Epirubicin Hydrochloride in naïve Intermediate-risk NMIBC Patients
Sponsor:
Jiangsu Yahong Meditech Co., Ltd aka Asieris
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-muscle Invasive Bladder Cancer | View |
Keywords: